Zhang Han Cheng, White Kimberly B, McComsey David F, Addo Michael F, Andrade-Gordon Patricia, Derian Claudia K, Oksenberg Donna, Maryanoff Bruce E
Drug Discovery, Johnson & Johnson Pharmaceutical Research & Development, 19477-0776, Spring House, PA, USA.
Bioorg Med Chem Lett. 2003 Jul 7;13(13):2199-203. doi: 10.1016/s0960-894x(03)00325-1.
A new generation of indole-based peptide mimetics, bearing a basic amine at the C-terminus, was developed by the agency of two complementary, multistep, trityl resin-based approaches. Thus, we obtained several high-affinity thrombin receptor (PAR-1) ligands, such as 32 and 34. Compounds 32 and 34 were found to bind to PAR-1 with excellent affinity (IC(50)=25 and 35 nM, respectively) and to effectively block platelet aggregation induced by SFLLRN-NH(2) (TRAP-6) and alpha-thrombin.